Differences

This shows you the differences between two versions of the page.

--- research:pgx_drug_exposure [2015/03/11 10:37] – rkboyce
+++ research:pgx_drug_exposure [2017/01/15 00:04] (current) – rkboyce
@@ Line 11: / Line 11: @@
 **Coordinating Institution(s):** University of Pittsburgh, Medical University of Vienna, Columbia University, Regenstrief Institute, Janssen R&D, AstraZeneca
-** Additional Participants (currently seeking other collaborators):**  Patrick Ryan, Jon Duke, George Hripcsak, Abraham G. Hartzema, Christian Reich
+** Additional Participants (currently seeking other collaborators):**  Patrick Ryan, Jon Duke, George Hripcsak, Abraham G. Hartzema, Christian Reich, Dan Malone
 **Full Protocol:** [[https://docs.google.com/document/d/1u3AE5DtkEp3m8OcbwkGHtXBVefYGGJ_1RMO3OnqpXiY/edit|Google doc for the protocol]]
@@ Line 17: / Line 17: @@
 **Initial Proposal Date:**  2/16/2015
-**Launch Date:**  //<fill out once finalized>//
+**Launch Date:**  This was a test research network study and has met its objectives as of 12/1/2016.
 **Study Closure Date:  //<fill out once finalized>//**
@@ Line 38: / Line 38: @@
 ===== Discussion =====
-[[http://forums.ohdsi.org/t/ohdsi-study-3-incidence-of-exposure-to-drugs-for-which-pre-emptive-pharmacogenomic-testing-is-available/387]]//
+[[http://forums.ohdsi.org/t/ohdsi-study-3-incidence-of-exposure-to-drugs-for-which-pre-emptive-pharmacogenomic-testing-is-available/387]]
 ===== Datasets Run =====